Pro Share Advisors LLC Cytek Biosciences, Inc. Transaction History
Pro Share Advisors LLC
- $36.5 Billion
- Q2 2024
A detailed history of Pro Share Advisors LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 18,147 shares of CTKB stock, worth $91,823. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,147
Previous 23,941
24.2%
Holding current value
$91,823
Previous $160,000
36.88%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CTKB
# of Institutions
128Shares Held
74.7MCall Options Held
200Put Options Held
100-
Black Rock Inc. New York, NY17.1MShares$86.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$59.4 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD11.4MShares$57.6 Million1.3% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$33.7 Million0.96% of portfolio
-
State Street Corp Boston, MA3.97MShares$20.1 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $681M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...